Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewGen Biologics is an Indian biotechnology company specializing in the research, development, and large-scale manufacture of industrial enzymes, probiotics, and nutraceutical ingredients. The company serves a diverse range of sectors, including pharmaceuticals, human nutrition, animal health, food processing, and textiles. Their core expertise lies in advanced fermentation technology and protein engineering, allowing them to produce high-purity biological products such as alpha-amylase, protease, and various Bacillus-based probiotics. NewGen Biologics operates as both a product manufacturer and a contract development and manufacturing organization (CDMO), providing customized biological solutions to global industrial partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewGen Biologics.